摘要
药品不良反应主动监测是被动监测的重要补充。本文旨在明确主动监测与被动监测的区别,探究主动监测的发展历程和发展趋势,讨论大数据背景下主动监测的利弊,为国内开展药品不良反应主动监测提供思路及方向。
Active surveillance of adverse drug reaction(ADR) is an important supplement to passive ADR monitoring. In this article, we aim to make clear the difference between active and passive monitoring, explore the development process and trend of active surveillance, discuss the pros and cons of active surveillance under the background of big data, and provide ideas and direction for its practice in China.
出处
《中国药物警戒》
2015年第10期600-602,610,共4页
Chinese Journal of Pharmacovigilance